Shanghai Junshi (China) Investor Sentiment

688180 Stock   29.36  0.77  2.56%   
About 62% of Shanghai Junshi's investor base is looking to short. The analysis of the overall investor sentiment regarding Shanghai Junshi Biosciences suggests that many traders are alarmed. The current market sentiment, together with Shanghai Junshi's historical and current headlines, can help investors time the market. In addition, many technical investors use Shanghai Junshi Bios stock news signals to limit their universe of possible portfolio assets.
  
over two weeks ago at news.google.com         
Shanghai Junshi Biosciences Proposes New Board Members - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Shanghai Junshi Biosciences UK Approval for Cancer Drug - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Shanghai Junshi Biosciences Reduces Major Shareholders Stakes - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Shanghai Junshi Biosciences Faces Board Vacancy - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Is Shanghai Junshi Biosciences Using Debt Sensibly - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
Junshi Biosciences Announces Global Licensing Deal - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Junshi Biosciences Major Shareholders Plan to Reduce Stakes - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Junshi narrows its losses but delivers no cure for share price woes - Bamboo Works
Google News at Macroaxis
over three months ago at news.google.com         
Shanghai Junshi Biosciences Announces Reorganization - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Shanghai Junshi Biosciences Co., Ltd.s Revenues Are Not Doing Enough For Some Investors - Simply Wal...
Google News at Macroaxis
over three months ago at news.google.com         
Junshi Biosciences Schedules Key Financial Review - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Junshi Biosciences Drug Nears EU Approval - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Shanghai Junshi Biosciences Has Debt But No Earnings Should You Worry - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Junshi Biosciences Shareholders Approve Key Resolutions - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
retail investors who own 51 percent along with institutions invested in Shanghai Junshi Biosciences ...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Shanghai Junshi that are available to investors today. That information is available publicly through Shanghai media outlets and privately through word of mouth or via Shanghai internal channels. However, regardless of the origin, that massive amount of Shanghai data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Shanghai Junshi news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Shanghai Junshi relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Shanghai Junshi's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Shanghai Junshi alpha.

Shanghai Junshi Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Junshi Biosciences Major Shareholders Plan to Reduce Stakes - TipRanks
09/24/2024
2
Shanghai Junshi Biosciences Faces Board Vacancy - TipRanks
10/23/2024
3
Shanghai Junshi Biosciences Proposes New Board Members - TipRanks
11/29/2024

Complementary Tools for Shanghai Stock analysis

When running Shanghai Junshi's price analysis, check to measure Shanghai Junshi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Junshi is operating at the current time. Most of Shanghai Junshi's value examination focuses on studying past and present price action to predict the probability of Shanghai Junshi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Junshi's price. Additionally, you may evaluate how the addition of Shanghai Junshi to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals